V

Vericel Corp
D

VCEL

58.140
USD
1.46
(2.58%)
Market Open
Volume
1,478
EPS
0
Div Yield
-
P/E
724
Market Cap
2,860,319,744
OverviewSignalsIdeasNews
Related Instruments
    A
    ABMD
    0
    (0%)
    0.000000 USD
    A
    ALGN
    2.230
    (1.01%)
    223.930 USD
    B
    BAX
    0.260
    (0.82%)
    31.970 USD
    BSX
    BSX
    -0.590
    (-0.67%)
    87.000 USD
    EW
    EW
    1.620
    (2.45%)
    67.780 USD
    ISRG
    ISRG
    -10.30
    (-1.92%)
    546.67 USD
    M
    MTD
    -57.09
    (-4.61%)
    1,180.92 USD
    RMD
    RMD
    3.500
    (1.51%)
    234.840 USD
    S
    STE
    -0.945
    (-0.43%)
    220.290 USD
    TMO
    TMO
    -19.95
    (-3.74%)
    514.535 USD
    More
News

Title: Vericel Corp

Sector: Healthcare
Industry: Biotechnology
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company, specialized in various therapies for sports medicine and severe burn care markets. It markets two cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane) and Epicel (cultured epidermal autografts). The company operates in one reportable segment: the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of specific diseases.